Consistently, the inhibition of gut inflammation can significantly protect against intestinal barrier damage and inhibit CRC.[49, 50] Notably, our studies showed that GA treatment can significantly inhibit the expression of pro‐inflammatory cytokines IL‐1β, IL‐6, and TNF‐α in UC mice and intestinal organoids. This evidence concerns the gene IL6 and colorectal carcinoma.